The process of cardiac metabolic remodeling in patients with CKD is characterized by various forms of cardiac metabolic maladaptation including altered mitochondrial function, myocardial substrate utilization, metabolic transporter function and expression, and impaired insulin response and phosphoinositide-3 kinase-AKT signaling, leading to impaired cardiac function [19]. Here, INS is linked to chronic kidney disease.